Discussion 'Myeloma'
Multiple Myeloma Stem Cells and Drug Resistance in Myeloma Management
Multiple myeloma is a heterogenous plasma cell disorder that contains a small fraction of clonogenic stem cells, just like many other cancers. Although…
Understanding the FDA approved New Drug, Selinexor and its Use in Multiple Myeloma
Recently, the FDA approved a new cancer drug called Selinexor. This drug has been found to be successful in treating multiple myeloma in…
The Promise of Prevention. Multiple Myeloma and The Promise Study
Nearly all patients with multiple myeloma first develop one of its precursor conditions. People with these conditions do not have any symptoms, and…
ASCO 2019 Highlights: Advances in Multiple Myeloma
ASCO 2019 conluded on 4th June 2019 and we are excited about Multiple Myeloma updates from the largest gathering of oncologists, researchers and…
Transplants and Risk Adapted Maintenance in Myeloma Treatment
The treatment paradigm for myeloma patients has changed in the last decade with important advancements such as proteasome inhibitors, IMiDS, antibodies and risk-adapted…